Johnson & Johnson's COVID-19 Vaccine Inventory Is Lighter Than Expected

The White House COVID-19 Response Team held a briefing on Wednesday where Joe Biden's recently appointed COVID-19 response coordinator, Jeff Zients, told the public some news we weren't happy to hear. It looks like the U.S. government will only have a few million doses of Johnson & Johnson's (NYSE:JNJ) coronavirus vaccine candidate in inventory by the end of February.